Terms: = Liver cancer AND RAC1, ENSG00000136238, 5879, MIG5, MGC111543, P63000, p21-Rac1, TC-25
164 results:
1. Protease-activated receptor 2 drives migration in a colon cancer cell line but not in noncancerous human epithelial cells.
Périco LL; Vegso AJ; Baggio CH; MacNaughton WK
Am J Physiol Gastrointest Liver Physiol; 2024 May; 326(5):G525-G542. PubMed ID: 38440826
[TBL] [Abstract] [Full Text] [Related]
2. Tumour-associated macrophage-derived DOCK7-enriched extracellular vesicles drive tumour metastasis in colorectal cancer via the rac1/ABCA1 axis.
Chen W; Zhou M; Guan B; Xie B; Liu Y; He J; Zhao J; Zhao Q; Yan D
Clin Transl Med; 2024 Feb; 14(2):e1591. PubMed ID: 38385857
[TBL] [Abstract] [Full Text] [Related]
3. HMGB1 promotes mitochondrial transfer between hepatocellular carcinoma cells through RHOT1 and rac1 under hypoxia.
Jing M; Xiong X; Mao X; Song Q; Zhang L; Ouyang Y; Pang Y; Fu Y; Yan W
Cell Death Dis; 2024 Feb; 15(2):155. PubMed ID: 38378644
[TBL] [Abstract] [Full Text] [Related]
4. Tigecycline causes loss of cell viability mediated by mitochondrial OXPHOS and rac1 in hepatocellular carcinoma cells.
Koch DT; Yu H; Beirith I; Schirren M; Drefs M; Liu Y; Knoblauch M; Koliogiannis D; Sheng W; De Toni EN; Bazhin AV; Renz BW; Guba MO; Werner J; Ilmer M
J Transl Med; 2023 Dec; 21(1):876. PubMed ID: 38041179
[TBL] [Abstract] [Full Text] [Related]
5. Significant Reduction in Posttransplant Hepatocellular Carcinoma Recurrence in the Post 6-Mo Waiting Policy Era.
Mahmud N; Yagan L; Hoteit MA; Reddy KR; Abt PL; Abu-Gazala S
Transplantation; 2024 May; 108(5):1172-1178. PubMed ID: 37953481
[TBL] [Abstract] [Full Text] [Related]
6. Integrated analysis of tumour-derived exosome-related immune genes to predict progression and immune status of hepatocellular carcinoma.
Li W; Zhao B; Wang Q; Lu J; Wu X; Chen X
Clin Immunol; 2023 Nov; 256():109774. PubMed ID: 37774907
[TBL] [Abstract] [Full Text] [Related]
7. LANCL1, a cell surface protein, promotes liver tumor initiation through FAM49B-rac1 axis to suppress oxidative stress.
Huang H; Tsui YM; Ho DW; Chung CY; Sze KM; Lee E; Cheung GC; Zhang VX; Wang X; Lyu X; Ng IO
Hepatology; 2024 Feb; 79(2):323-340. PubMed ID: 37540188
[TBL] [Abstract] [Full Text] [Related]
8. Identification and validation of novel signature associated with hepatocellular carcinoma prognosis using Single-cell and WGCNA analysis.
Song H; Ge Y; Xu J; Shen R; Zhang PC; Wang GQ; Liu B
Int J Med Sci; 2023; 20(7):870-887. PubMed ID: 37324188
[No Abstract] [Full Text] [Related]
9. Identification of
Permtermsin C; Lalchungnunga H; Nakjang S; Casement J; Ogle LF; Reeves HL; Strathdee G; Shukla R
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047360
[TBL] [Abstract] [Full Text] [Related]
10.
Kim JL; Kim SG; Natsagdorj E; Chung H; Cho SJ
Gut Liver; 2023 Sep; 17(5):741-752. PubMed ID: 36718103
[TBL] [Abstract] [Full Text] [Related]
11. The phospholipid flippase ATP9A enhances macropinocytosis to promote nutrient starvation tolerance in hepatocellular carcinoma.
Wang X; Li Y; Xiao Y; Huang X; Wu X; Zhao Z; Yang M; Kong L; Shi D; Chen X; Ouyang Y; Chen X; Lin C; Li J; Song L; Lin Y; Guan J
J Pathol; 2023 May; 260(1):17-31. PubMed ID: 36715683
[TBL] [Abstract] [Full Text] [Related]
12. Clinical Significance of Combined Epithelial-Mesenchymal Transition Markers Expression and Role of rac1 in Hepatocellular Carcinoma.
Shin SK; Ryu S; Nam S; Ha SY; Kwon OS; Kim YS; Kim SH; Kim JH
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675278
[TBL] [Abstract] [Full Text] [Related]
13. A20 interacts with mTORC2 to inhibit the mTORC2/Akt/rac1 signaling axis in hepatocellular carcinoma cells.
Wang X; Xiao Y; Dong Y; Wang Z; Yi J; Wang J; Wang X; Zhou H; Zhang L; Shi Y
Cancer Gene Ther; 2023 Mar; 30(3):424-436. PubMed ID: 36411371
[TBL] [Abstract] [Full Text] [Related]
14. N
Liu J; Zhang N; Zeng J; Wang T; Shen Y; Ma C; Yang M
Clin Transl Med; 2022 Nov; 12(11):e1107. PubMed ID: 36354136
[TBL] [Abstract] [Full Text] [Related]
15. In Silico and In Vitro Studies on the Mechanisms of Chinese Medicine Formula (Yiqi Jianpi Jiedu Formula) in the Treatment of Hepatocellular Carcinoma.
Wu Z; Kang J; Tan W; Wei C; He L; Jiang X; Peng L
Comput Math Methods Med; 2022; 2022():8669993. PubMed ID: 36345477
[TBL] [Abstract] [Full Text] [Related]
16. Spiropachysine A suppresses hepatocellular carcinoma proliferation by inducing methuosis in vitro and in vivo.
Fang Y; Zhong T; Yang L; Luo F; Li Q; Wang D; Li Q; Fan Y; Yang X
Phytomedicine; 2022 Jul; 102():154151. PubMed ID: 35584581
[TBL] [Abstract] [Full Text] [Related]
17. FMRP ligand circZNF609 destabilizes rac1 mRNA to reduce metastasis in acral melanoma and cutaneous melanoma.
Shang Q; Du H; Wu X; Guo Q; Zhang F; Gong Z; Jiao T; Guo J; Kong Y
J Exp Clin Cancer Res; 2022 May; 41(1):170. PubMed ID: 35534866
[TBL] [Abstract] [Full Text] [Related]
18. miR-21-5p/Tiam1-mediated glycolysis reprogramming drives breast cancer progression via enhancing PFKL stabilization.
Li N; Wang X; Sun J; Liu Y; Han A; Lin Z; Yang Y
Carcinogenesis; 2022 Aug; 43(7):705-715. PubMed ID: 35511493
[TBL] [Abstract] [Full Text] [Related]
19. Overexpressed or hyperactivated rac1 as a target to treat hepatocellular carcinoma.
Sauzeau V; Beignet J; Vergoten G; Bailly C
Pharmacol Res; 2022 May; 179():106220. PubMed ID: 35405309
[TBL] [Abstract] [Full Text] [Related]
20. Vav1 Promotes B-Cell Lymphoma Development.
Shalom B; Farago M; Salaymeh Y; Sebban S; Pikarsky E; Katzav S
Cells; 2022 Mar; 11(6):. PubMed ID: 35326399
[TBL] [Abstract] [Full Text] [Related]
[Next]
